Cargando…

In Vitro Release and In Vivo Pharmacokinetics of Praziquantel Loaded in Different Polymer Particles

Approximately 1 billion people are affected by neglected diseases around the world. Among these diseases, schistosomiasis constitutes one of the most important public health problems, being caused by Schistosoma mansoni and treated through the oral administration of praziquantel (PZQ). Despite being...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pereira, Emiliane Daher, da Silva Dutra, Luciana, Paiva, Thamiris Franckini, de Almeida Carvalho, Larissa Leite, Rocha, Helvécio Vinícius Antunes, Pinto, José Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10180028/ https://www.ncbi.nlm.nih.gov/pubmed/37176262 http://dx.doi.org/10.3390/ma16093382

Ejemplares similares

In vitro and in vivo human metabolism and pharmacokinetics of S‐ and R‐praziquantel
por: Kapungu, Nyasha Nicole, et al.
Publicado: (2020)

The Effect of Polymer Blends on the In Vitro Release/Degradation and Pharmacokinetics of Moxidectin-Loaded PLGA Microspheres
por: Zhang, Hongjuan, et al.
Publicado: (2023)

Evaluation of the pharmacokinetic-pharmacodynamic relationship of praziquantel in the Schistosoma mansoni mouse model
por: Abla, Nada, et al.
Publicado: (2017)

Extrapolation of praziquantel pharmacokinetics to a pediatric population: a cautionary tale
por: Bonate, Peter L., et al.
Publicado: (2018)

Effect of Dihydroartemisinin-Piperaquine on the Pharmacokinetics of Praziquantel for Treatment of Schistosoma mansoni Infection
por: Minzi, Omary Mashiku, et al.
Publicado: (2021)

Population Pharmacokinetics of Praziquantel in Pregnant and Lactating Filipino Women Infected with Schistosoma japonicum
por: Bustinduy, Amaya L., et al.
Publicado: (2020)

In vitro/vivo assessment of praziquantel nanocrystals: Formulation, characterization, and pharmacokinetics in beagle dogs
por: Yang, Ruyi, et al.
Publicado: (2019)

Resolution of Praziquantel
por: Woelfle, Michael, et al.
Publicado: (2011)

Praziquantel–Clays as Accelerated Release Systems to Enhance the Low Solubility of the Drug
por: Borrego-Sánchez, Ana, et al.
Publicado: (2020)

The Role of Efflux Pumps in Schistosoma mansoni Praziquantel Resistant Phenotype
por: Pinto-Almeida, António, et al.
Publicado: (2015)

Pharmacokinetics of a novel endectoparasiticide topical formulation for cats, combining esafoxolaner, eprinomectin and praziquantel
por: Jacquot, Virginie, et al.
Publicado: (2021)

Praziquantel, Mefloquine-Praziquantel, and Mefloquine-Artesunate-Praziquantel against Schistosoma haematobium: A Randomized, Exploratory, Open-Label Trial
por: Keiser, Jennifer, et al.
Publicado: (2014)

Anaphylactic reaction to praziquantel following schistosomiasis treatment
por: Vasconcelos, Géssica Almeida, et al.
Publicado: (2023)

Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel
por: Amer, Eglal I., et al.
Publicado: (2022)

Slow-release praziquantel for dogs: presentation of a new formulation for echinococcosis control
por: Jiang, Bin, et al.
Publicado: (2017)

Preparation and In Vitro/In Vivo Evaluation of Orally Disintegrating/Modified-Release Praziquantel Tablets
por: Wen, Xuemei, et al.
Publicado: (2021)

Clinically relevant enantiomer specific R‐ and S‐praziquantel pharmacokinetic drug‐drug interactions with efavirenz and ritonavir
por: Mutiti, Chenai Sheilla, et al.
Publicado: (2021)

Praziquantel-Solid Lipid Nanoparticles Produced by Supercritical Carbon Dioxide Extraction: Physicochemical Characterization, Release Profile, and Cytotoxicity
por: Andrade, Luciana N., et al.
Publicado: (2019)

THE SUSCEPTIBILITY OF RECENT ISOLATES OF Schistosoma mansoni TO PRAZIQUANTEL
por: MENDONÇA, Adriana Maria B., et al.
Publicado: (2016)

Immunization with tegument nucleotidases associated with a subcurative praziquantel treatment reduces worm burden following Schistosoma mansoni challenge
por: Rofatto, Henrique K., et al.
Publicado: (2013)

Population Pharmacokinetics and Pharmacodynamics of Praziquantel in Ugandan Children with Intestinal Schistosomiasis: Higher Dosages Are Required for Maximal Efficacy
por: Bustinduy, Amaya L., et al.
Publicado: (2016)

The cytotoxicity study of praziquantel enantiomers
por: Sun, Qian, et al.
Publicado: (2016)

Promotion of Rat Hepatocarcinogenesis by Praziquantel
por: Shirai, Tomoyuki, et al.
Publicado: (1991)

In vivo assessment of the antischistosomal activity of curcumin loaded nanoparticles versus praziquantel in the treatment of Schistosoma mansoni
por: Mokbel, Kamal El-Din M., et al.
Publicado: (2020)

A Paragonimiasis Patient with Allergic Reaction to Praziquantel and Resistance to Triclabendazole: Successful Treatment after Desensitization to Praziquantel
por: Kyung, Sun Young, et al.
Publicado: (2011)

In Vivo Evaluation of Praziquantel-Loaded Solid Lipid Nanoparticles against S. mansoni Infection in Preclinical Murine Models
por: Adekiya, Tayo A., et al.
Publicado: (2022)

Praziquantel degradation in marine aquarium water
por: Thomas, Amber, et al.
Publicado: (2016)

Morphological Characteristics of Schistosoma mansoni PZQ-Resistant and -Susceptible Strains Are Different in Presence of Praziquantel
por: Pinto-Almeida, António, et al.
Publicado: (2016)

In vivo Pharmacokinetics and in vitro Release of Imatinib Mesylate-Loaded Liposomes for Pulmonary Delivery
por: Xu, Hongfei, et al.
Publicado: (2021)

Drug metabolism and pharmacokinetics of praziquantel: A review of variable drug exposure during schistosomiasis treatment in human hosts and experimental models
por: Zdesenko, Grace, et al.
Publicado: (2020)

Synergy of Omeprazole and Praziquantel In Vitro Treatment against Schistosoma mansoni Adult Worms
por: Almeida, Giulliana T., et al.
Publicado: (2015)

Hypersensitive Reaction to Praziquantel in a Clonorchiasis Patient
por: Lee, Jung-Min, et al.
Publicado: (2011)

Praziquantel Treatment in Trematode and Cestode Infections: An Update
por: Chai, Jong-Yil
Publicado: (2013)

Albendazole and Praziquantel: Review and Safety Monitoring in Korea
por: Hong, Sung-Tae
Publicado: (2018)

Praziquantel for the treatment of schistosomiasis during human pregnancy
por: Friedman, Jennifer F, et al.
Publicado: (2018)

Effect of Praziquantel on Schistosoma mekongi Proteome and Phosphoproteome
por: Chienwichai, Peerut, et al.
Publicado: (2020)

Development of Praziquantel sulphonamide derivatives as antischistosomal drugs
por: Angeli, Andrea, et al.
Publicado: (2022)

Effects of praziquantel on common carp embryos and larvae
por: Velisek, Josef, et al.
Publicado: (2022)

In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium
por: Kovač, Jana, et al.
Publicado: (2017)

The Preparation and Characterization of Chitooligosaccharide–Polylactide Polymers, and In Vitro Release of Microspheres Loaded with Vancomycin
por: Li, Jiaxin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mg92mgjapanffs56tfveaeqeq4